References
- Geoffrey DT, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R. Nosocomial Gram-negative bacteremia. Int J Infect Dis 1997; 1: 202–205.
- Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, Martino P. Bacteremia due to Strenotrophomonas maltophilia in patients with haematolog-ic malignancies. Clin Infect Dis 2000; 31: 705–11.
- Alonso A, Martinez JL. Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1997: 1140-1142.
- Valles J, Leon C, Lerma FA. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiolo-gy and prognosis. Clin Infect Dis 1997; 24: 387–95.
- Rubinstein E, Levy I. Acinetobacter spp., Pseudomonas spp. and other non-fermentative pathogens causing nosocomi-al bacteremias. Clin Microbiol Infect 1999; 5: 2S29-2S32.
- Bilikova E, Koprnova J, Hafed BM, et al. Nosocomial enterococcal infection in neonates. Int J Infect Dis 2004; 8 (2): 127–129.
- Koprnova J, Svetlansky I, Babela R, et al. Prospective study on antibacterial susceptibility, risk factors and outcome of 157 episodes of Acinetobacter baumanii bacteremia in 1999 in Slovakia. Scand J Infect Dis 2001; 33 (12): 891–895.
- Souza E, Perez-Molina J, Munoz P, and ESGNI. Report of ESGNI -001 and ESGNI-002 studies. Bloodstream infec-tions in Europe. Clin Microbiol Infect 1999; 5: 2S1-2S12.
- Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ, and the French and Portuguese ICU Study Groups: Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. JAMA. 1999; 281: 67–71.
- Diekema DJ, Pfaller MA, Jones RN, et al, and the SEN-TRY participants group. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. Int J Antimicrob Agents 2000; 13: 257–271.
- Krcmery V, Tomas L, Mardiak J, Spanik S. Bacteremia due to imipenem resistant Pseudomonas aeruginosa. Drugs Clin Exp Res 1994; 25: 336–353.
- Fortun J, Navas E. A critical approach to the pathogen-esis, diagnosis, treatment and prevention of catheter-related bloodstream infections and nosocomial endocarditis. Clin Microbiol Infect 1999; 5: 2S40-2S50.
- Krcmery V Jr, Pichna P, Oravcová E, et al. Stenotrophomonas maltophilia bacteremia in cancer patients: report on 31 cases. J Hosp Infect 1996; 20: 75–77.
- Spencer RC: The emergence of epidemic, multiple-antibiotic resistance Stenotrophomonas (Xanthomonas) mal-tophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30: Suppl. 453-464.
- Klastersky J, and the EORTC study group: Short versus conventional course of amikacin, both with ceftazidime in empiric therapy of febrile neutropenia. Am J Med 1993; 102: 1136–1142.
- Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. Adding aminoglycoside to betalactam does not improve results. Br Med J 2004; 328 (7441): 668.
- Blahova J, Kralikova K, Krcmery V Sr, et al. Monitoring of antibiotic resistance in bacterial isolates from bacteremic patients. J Chemother 2004; 16: 269–72.